Aug 2026· Molecular Carcinogenesis· Vol 65, pp. 1383 - 1397· 0 citations· 55 references
Medicine
TL;DR
Results indicated that BMJ shifted the pancreatic tumor profile from moderately differentiated adenocarcinoma in controls towards a more heterogeneous profile enriched for well‐differentiated lesions indicating that prolonged exposure to BMJ bioactives results in a less aggressive phenotype.
Abstract
Herein, using the LSL‐KrasG12D/+; p48Cre/+ transgenic mouse model [that recapitulates the full spectrum of human disease, progressing from early pancreatic intraepithelial neoplasia lesions to invasive pancreatic ductal adenocarcinoma (PDAC)], we determined the chemopreventive effect of long‐term (chronic) administration of Bitter Melon Juice (BMJ‐standardized lyophilized juice processed from the fruits of Momordica charantia) against pancreatic cancer. Starting at 6 weeks of age, female LSL‐KrasG12D/+; p48Cre/+ mice were subjected to BMJ intervention (oral gavage, dose: 200 mg/kg body wt., 5 days/week) for 35 weeks (study end: 41 weeks of age), and pathological and molecular changes in the pancreas were assessed. Results indicated that BMJ shifted the pancreatic tumor profile from moderately differentiated adenocarcinoma in controls towards a more heterogeneous profile enriched for well‐differentiated lesions indicating that prolonged exposure to BMJ bioactives results in a less aggressive phenotype. BMJ significantly reduced proliferative index (~24%) and induced a ~ 4‐fold increase in apoptosis in the pancreas. The effects on AMPK activation (~2‐fold increase) and decrease in the expression of [glucose (GLUT‐1) and lactate (MCT‐4) transporter levels (∼49%–69%,), NF‐κB/p65 (~40%), EMT marker‐Vimentin (~46%), fibrotic microenvironment marker (α‐SMA, ~29%) and Mucin‐1 (MUC‐1, ~45%)] indicate that BMJ modulates several interconnected pathways essential for PDAC growth and progression. Plasma proteomic profiling indicated that Fractalkine (CX3CL1), MIP‐3β (CCL19), MIP‐3α (CCL20), and SCF were decreased by BMJ, while Axl and TNF‐alpha were overexpressed in BMJ‐treated animals compared to positive controls. These results encourage further research into bitter melon compounds as a potential chemopreventive option for pancreatic cancer, especially for high‐risk groups.
The modified 4NQO model provides a robust platform for stage-specific chemoprevention evaluation, with black tea polyphenols, particularly decaffeinated extracts, demonstrating modest progression-modulating effects that warrant further investigation.
Sakshi S. Anchan, Pooja S. Kohinkar, Yadnyesh G. Bhandari et al.· Carcinogenesis· 0 citations
Conventional chemotherapeutic treatment of colorectal cancer causes adverse effects such as severe diarrhoea, mucositis and hepatotoxicity. This study aimed to investigate the anti-carcinogenic potential of epigallocatechin-3-gallate and its effects on major angiogenic markers, alone and in combination with irinotecan...
Sabana Rahman, Sukanya Baruah, Nabila Akhtara et al.· Journal of the Egyptian Nati...· 0 citations
BACKGROUND
Corticosteroid toxicity can predispose individuals to metabolic dysfunction-associated steatotic liver disease (MASLD), which may progress to metabolic dysfunction-associated steatohepatitis (MASH). Date palm fruit (Phoenix dactylifera L.) is widely recognized as a nutraceutical due to its rich content of bi...
Rasha M. S. M. Mohamed, N. H. Hassan, Sherein F. El-sayed et al.· Tissue & Cell· 0 citations
Background: Cachexia is common in gastrointestinal (GI) cancers in general and pancreatic ductal adenocarcinoma (PDAC) in particular. PDAC has one of the highest prevalences and earliest onsets of cancer cachexia, affecting up to 90% of patients. Furthermore, the extent of weight lost among patients with PDAC exceeds...
M. Joly, W. Riedl, W. Grant et al.· Cancer Research· 0 citations
Results established that supplementation with p-MCA and the reference drug (sorafenib) to NDEA induced rats significantly decreased the incidence of cancer in the liver, besides altering the phase I and phase II xenobiotic enzymes.
Sriragavi Ravi, Rajagopal Ayyanar, N. Namasivayam· Journal of Science & Tec...· 2 citations
Targeting ferroptosis has emerged as a promising anti-cancer strategy. A Food and Drug Administration (FDA)-approved drug, sulfasalazine (SAS), also a ferroptosis inducer, is being explored as a potential treatment drug for cancer. However, long-term high-dose SAS treatment may induce several adverse effects in the...
Kai Han, Jia-Yuan Li, Bing-Ying Shuai et al.· Food & Medicine Homology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.